Suppression of NK cell function by platelet-derived microparticles: implications for transfusion-related...

Area of Science:

• Immunology
• Cell Biology
• Transfusion Medicine

Background:

• Platelet-derived microparticles (PMPs) are released from platelets and can influence immune cell function.
• The immunomodulatory effects of PMPs, particularly those from stored platelets, on innate immunity are not fully understood.
• NK cells are crucial components of the innate immune system, mediating anti-viral and anti-tumor responses.

Purpose of the Study:

• To investigate the effects of PMPs from stored platelets on natural killer (NK) cell function in vitro.
• To identify potential molecular mechanisms, including microRNAs (miRNAs), involved in PMP-mediated NK cell modulation.
• To validate findings in a clinical context using samples from sepsis patients.

Main Methods:

• PMPs were isolated from stored platelets and co-cultured with peripheral blood mononuclear cells (PBMCs) or primary NK cells.
• NK cell activation, cytotoxicity, and interferon-gamma (IFN-γ) secretion were assessed by flow cytometry.
• Gene expression (qRT-PCR) and small RNA sequencing were used to identify functional mediators, with miR-223-3p identified as a candidate.

Main Results:

• PMPs from stored platelets modulated NK cell activation, IFN-γ production, and cytotoxic molecule expression in a concentration-dependent manner.
• PMP treatment reduced NK cell-mediated killing of K562 target cells.
• Results suggest post-transcriptional regulation, potentially mediated by miR-223-3p, contributes to PMP-induced NK cell dysfunction.
• Ex vivo validation in sepsis patients supported PMP-mediated NK cell modulation in clinical settings.

Conclusions:

• PMPs accumulating in stored platelets can suppress NK cell function, contributing to transfusion-related immunomodulation.
• MiR-223-3p is identified as a potential mediator of PMP-induced NK cell modulation.
• PMP-mediated NK cell dysfunction may play a role in immune dysregulation observed in clinical conditions like sepsis, where platelet transfusions are common.